Header Logo

Connection

Mark Pollack to Mental Disorders

This is a "connection" page, showing publications Mark Pollack has written about Mental Disorders.
Connection Strength

0.356
  1. Innovative uses of benzodiazepines in psychiatry. Can J Psychiatry. 1993 Nov; 38 Suppl 4:S122-6.
    View in: PubMed
    Score: 0.101
  2. Calcium channel blockers in psychiatry. Psychosomatics. 1987 Jul; 28(7):356-60, 369.
    View in: PubMed
    Score: 0.065
  3. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004 Oct; 24(5):512-20.
    View in: PubMed
    Score: 0.054
  4. Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission. J Clin Psychiatry. 2001; 62 Suppl 19:20-5.
    View in: PubMed
    Score: 0.041
  5. How do clinicians respond to patients who miss appointments? J Clin Psychiatry. 1998 Jun; 59(6):330-8; quiz 339-40.
    View in: PubMed
    Score: 0.035
  6. Sleep panic attacks: an association with childhood anxiety and adult psychopathology. Biol Psychiatry. 1994 Jul 01; 36(1):57-60.
    View in: PubMed
    Score: 0.026
  7. EFFECTS OF CHLORPROMAZINE AND IMIPRAMINE ON SYSTOLIC BLOOD PRESSURE IN PSYCHIATRIC PATIENTS: RELATIONSHIPS TO AGE, DIAGNOSIS AND INITIAL BLOOD PRESSURE. J Psychiatr Res. 1964 Jan; 2:51-60.
    View in: PubMed
    Score: 0.013
  8. Tachistoscopic perception after induced altered brain function: influence of mental set. J Nerv Ment Dis. 1962 May; 134:422-30.
    View in: PubMed
    Score: 0.011
  9. Sociopsychological characteristics of patients who refuse convulsive therapy. J Nerv Ment Dis. 1961 Feb; 132:153-7.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.